Your browser doesn't support javascript.
loading
A Cost Analysis of Phosphodiesterase Type 5 Inhibitors in the United States.
Nabavizadeh, Behnam; Nguyen, Amanda; Li, Diane; van Meijgaard, Jeroen; Breyer, Benjamin N.
Affiliation
  • Nabavizadeh B; Department of Urology, University of California San Francisco, San Francisco, CA; Department of Urology, Weill Cornell Medicine, New York, NY.
  • Nguyen A; GoodRx, Santa Monica, CA.
  • Li D; GoodRx, Santa Monica, CA.
  • van Meijgaard J; GoodRx, Santa Monica, CA.
  • Breyer BN; Department of Urology, University of California San Francisco, San Francisco, CA; Department of Biostatistics and Epidemiology, University of California San Francisco, San Francisco, CA. Electronic address: Benjamin.Breyer@ucsf.edu.
Urology ; 183: 127-133, 2024 Jan.
Article in En | MEDLINE | ID: mdl-37951363
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drugs, Generic / Phosphodiesterase 5 Inhibitors Limits: Humans Country/Region as subject: America do norte Language: En Journal: Urology Year: 2024 Document type: Article Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drugs, Generic / Phosphodiesterase 5 Inhibitors Limits: Humans Country/Region as subject: America do norte Language: En Journal: Urology Year: 2024 Document type: Article Country of publication: Estados Unidos